Medical device manufacturers are facing a lot of challenges

Opinion |  Features | By Suresh Vazirani | 1 Comment | 04 Jun, 2018

A lot has been spoken about recognizing the Medtech industry as a sunshine sector in the Government’s Make in India initiative. The move has been welcomed by the industry with open ar...Read more

THALASSEMIA CARE IN INDIA: WHERE DO WE STAND?

Opinion |  News | By Sunil Bhat | 0 Comment | 08 May, 2018

Blood, the life line of our bodies, has three major cellular components: red cells, white cells and platelets.  Red cells provide energy and transport oxygen in the body.  In Thal...Read more

Addressing the Industry- Academia gap

Opinion |  Features | By Dr Manbeena Chawla | 0 Comment | 06 May, 2018

The evolving science in the biotech sector is leading to a demand for high-skilled jobs in India. However, a wide gap currently exists between the quality of human capital available and the...Read more

Is India poised to become a world leader in eliminating TB?

Opinion |  Features | By Dr Sanjay Sarin | 0 Comment | 27 Mar, 2018

Very recently, Prime Minister Shri Narendra Modi opened the Delhi End TB Summit 2018, highlighting India’s critical role in the global effort to end the tuberculosis (TB) epidemic in ...Read more

World Rare Disease Day- Prevention of Sickle Cell Disease: Early screening and awareness, ‘A MUST’

Opinion |  Features | By Dr Sheetal Sharda | 0 Comment | 28 Feb, 2018

There are about 2, 75,000 infants born with sickle cell anemia every year around the world. It is a major public health problem in India affecting mostly the tribal population and prevalent...Read more

An Evolutionary Perspective of Darwinism!

Opinion |  Features | 0 Comment | 21 Feb, 2018

Union minister of state for human resource development, Satyapal Singh had stated last month that the Darwin’s theory of evolution was scientifically wrong and proposed to drop it fro...Read more

Healthcare sector responds to Union Budget 2018

Opinion |  Features | 4 Comment | 03 Feb, 2018

The last full Budget of the present government played big on its flagship healthcare coverage, which was later dubbed as ‘ModiCare’. This is what the Healthcare sector want...Read more

Union Budget 2018: Outlook for Healthcare sector

Opinion |  Features | 0 Comment | 30 Jan, 2018

Each year, around the Union Budget, the Healthcare sector eagerly waits for some positive news regarding certain pressing issues, which remain unchanged for decades. Toward this, I sincerel...Read more

The ‘Trump’ card

Opinion |  Views | 0 Comment | 07 Dec, 2017

There is a blatant contradiction. On one hand, US President Donald Trump recently expressed concern over the prices of prescription drugs going out of control, describing the trend as the &...Read more

Virtual healthcare concerns

Opinion |  Views | 1 Comment | 12 Oct, 2017

E-commerce is an emerging market place for a large variety of commodities and objects. Going by the rising popularity of e-commerce websites, it is probably the most convenient market place...Read more

New era in medicine

Opinion |  Views | 0 Comment | 14 Sep, 2017

The US Food & Drug Administration (USFDA) has recently approved the first gene therapy for difficult-to-treat acute lymphoblastic leukemia. The promising medical breakthrough involves g...Read more

Overcoming dependency on China...

Opinion |  Views | 0 Comment | 22 Aug, 2017

Conflict with China at Doklam is bound to have ripples in different areas, political and economic. Pharma sector is also one of them going by the imports from China for making drugs. Thus, ...Read more

Fight on sub-standard drugs

Opinion |  Views | 0 Comment | 27 Jul, 2017

India’s Central Drugs Standard Control Organisation (CDSCO), the apex body for regulatory control working under the health ministry, has adopted two prong strategy to control the spre...Read more

Is ‘Right-to-try’ bill right?

Opinion |  Views | 0 Comment | 04 Jul, 2017

‘Right-to-try’ is being debated fiercely in US as the American Congress is considering a bill on the topic. It is a practice allowing patients diagnosed with terminal illnesses ...Read more

Stent Pricing: A right move

Opinion |  Views | 0 Comment | 19 May, 2017

Almost three months after the National Pharmaceutical Pricing Authority (NPPA) ceiling the maximum prices of cardiac stents, as expected, there have been complaints of non-compliance of the...Read more

Bionics potential largely untapped in India

Opinion |  Features | 1 Comment | 27 Apr, 2017

Artificial limbs that can help people walk, artificial eyes that help blind people see! Who knew that original body parts can be replaced by artificial ones. Welcome to the new world of bio...Read more

DermTech announces new pharma collaborations

Opinion |  News | By BioSpectrum Bureau | 0 Comment | 19 Apr, 2017

DermTech, Inc., the global leader in non-invasive molecular dermatology, has collaborated with two multi-national pharmaceutical companies. These two recent collaborations are further examp...Read more